long intergenic non-protein coding RNA 1320Genealiases: []
Q-omics provides the consensus-scored LINC01320 profile across patient tissues and cancer cell-line models. LINC01320 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in DLBC. Among the 18 cancer types available for tumor–normal comparison, LINC01320 is differentially expressed in 5, with the highest sampling consensus in KICH. Additionally, LINC01320 RNA expression shows 11,365 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight DLBC, KICH, and KIRP as cancer lineages where LINC01320 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01320 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01320 survival associations across molecular data types. LINC01320 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01320 RNA expression–survival associations across cancer types. High LINC01320 expression shows unfavorable associations in DLBC, ACC and KIRP, but favorable associations in HNSC, LUSC and CHOL. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify DLBC as the clearest survival context for LINC01320 RNA expression.
This table summarizes LINC01320 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01320. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01320 shows lower tumor expression in KICH, PRAD and ESCA and higher tumor expression in KIRC and COAD. The KICH box plot shows higher LINC01320 RNA expression in normal versus tumor tissue (log2 FC = −4.875, t-test p < 0.001).
This table shows molecular features associated with LINC01320 in patient tissues and cancer cell lines. In patient samples, LINC01320 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
